LIVE CELL IMAGING OF CD4+ T-CELL CHEMOKINESIS OVER IMMOBILIZED CCL21
LIVE CELL IMAGING OF CD4+ T-CELL CHEMOKINESIS OVER IMMOBILIZED CCL21
批准号:
7724055
负责人:
DAVID Alexander FRUMAN
金额:
$0.35万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2009-07-31
关键词:
5-(6)-carboxyfluorescein diacetate succinimidyl esterCCL21 geneCellsClassComputer Retrieval of Information on Scientific Projects DatabaseFundingGTP-Binding ProteinsGenerationsGlassGrantHourImageInstitutionLifeLipidsMusProtein IsoformsReceptor SignalingResearchResearch PersonnelResourcesSourceStaining methodStainsSystemT-LymphocyteToxinUnited States National Institutes of Healthcell motilitycellular imagingfluorescence microscopein vivo
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
In the mechanistic studies of PI3K regulatory subunit isoform contributions to chemokinesis, CCL21 will be immobilized on glass coverslips. WT and TdKO murine cells will be stained with CFSE or CMTMR, added to the CCL21-coated coverslips, and imaged for 30 minutes using an inverted wide-field fluorescence microscope. As a positive control for reduced motility, WT cells will be treated with pertussus toxin (inhibits class IB PI3K T-cell migration by blocking G-protein receptor signaling) for 2 hours. If a decrease in velocity in TdKO cells is observed, then this system is adequate in mimicking in vivo chemokinesis. If so, mechanistic studies studying cell polarization and PI3K lipid generation during chemokinesis will follow.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer
-
批准号:9178942
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2016
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer
-
批准号:9316613
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2016
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Regulation of B cell differentiation by eIF4E
-
批准号:9244731
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2016
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Combination strategies to enhance therapy for Ph-like B-ALL
-
批准号:8912208
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2015
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
UCI-GPS: UC Irvine Graduate Professional Success
-
批准号:9341983
-
项目类别:
-
资助金额:$31.79万
-
财政年份:2014
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
UCI-GPS: UC Irvine Graduate Professional Success
-
批准号:8929336
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2014
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
UCI-GPS: UC Irvine Graduate Professional Success
-
批准号:8829529
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2014
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Solving the elusive mechanism of rapamycin action in lymphocytes
-
批准号:8285697
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8628792
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Solving the elusive mechanism of rapamycin action in lymphocytes
-
批准号:8531852
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8815271
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8238745
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
TOR kinase inhibitors for leukemia therapy: mechanisms of action and resistance
-
批准号:8442848
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2012
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Immunoregulatory effects of novel mTOR inhibitors
-
批准号:7774553
-
项目类别:
-
资助金额:$7.2万
-
财政年份:2010
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Immunoregulatory effects of novel mTOR inhibitors
-
批准号:8019056
-
项目类别:
-
资助金额:$7.12万
-
财政年份:2010
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
PI3K Signaling in Single Lymphocytes Analyzed by LMS
-
批准号:6710897
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2004
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
PI3K Signaling in Single Lymphocytes Analyzed by LMS
-
批准号:6878064
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2004
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Phosphoinositide 3-Kinase Function in Lymphocytes
-
批准号:6837137
-
项目类别:
-
资助金额:$34.29万
-
财政年份:2002
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Phosphoinositide 3-Kinase Function in Lymphocytes
-
批准号:6620748
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2002
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
Phosphoinositide 3-Kinase Function in Lymphocytes
-
批准号:6609015
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2002
-
负责人:DAVID Alexander FRUMAN
-
依托单位:
海外基金